134 related articles for article (PubMed ID: 17679127)
1. Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction.
Miller CD; Roe MT; Mulgund J; Hoekstra JW; Santos R; Pollack CV; Ohman EM; Gibler WB; Peterson ED
Am J Med; 2007 Aug; 120(8):685-92. PubMed ID: 17679127
[TBL] [Abstract][Full Text] [Related]
2. Integrating "best of care" protocols into clinicians' workflow via care provider order entry: impact on quality-of-care indicators for acute myocardial infarction.
Ozdas A; Speroff T; Waitman LR; Ozbolt J; Butler J; Miller RA
J Am Med Inform Assoc; 2006; 13(2):188-96. PubMed ID: 16357360
[TBL] [Abstract][Full Text] [Related]
3. Adherence to beta-blocker therapy under drug cost-sharing in patients with and without acute myocardial infarction.
Schneeweiss S; Patrick AR; Maclure M; Dormuth CR; Glynn RJ
Am J Manag Care; 2007 Aug; 13(8):445-52. PubMed ID: 17685825
[TBL] [Abstract][Full Text] [Related]
4. Patient-Important Adverse Events of β-blockers in Frail Older Adults after Acute Myocardial Infarction.
Zullo AR; Olean M; Berry SD; Lee Y; Tjia J; Steinman MA
J Gerontol A Biol Sci Med Sci; 2019 Jul; 74(8):1277-1281. PubMed ID: 30137259
[TBL] [Abstract][Full Text] [Related]
5. Clinical Efficacy of Beta-1 Selective Beta-Blockers Versus Propranolol in Patients With Thyroid Storm: A Retrospective Cohort Study.
Matsuo Y; Jo T; Watanabe H; Matsui H; Fushimi K; Yasunaga H
Crit Care Med; 2024 Jul; 52(7):1077-1086. PubMed ID: 38551468
[TBL] [Abstract][Full Text] [Related]
6. Pediatric Beta Blocker Therapy: A Comprehensive Review of Development and Genetic Variation to Guide Precision-Based Therapy in Children, Adolescents, and Young Adults.
Walton M; Wagner JB
Genes (Basel); 2024 Mar; 15(3):. PubMed ID: 38540438
[TBL] [Abstract][Full Text] [Related]
7. Routine beta-blocker administration following acute myocardial infarction: why still an unsolved issue?
Noble S; Roffi M
J Thorac Dis; 2017 Nov; 9(11):4191-4194. PubMed ID: 29268468
[No Abstract] [Full Text] [Related]
8. Beta-blocker therapy in pediatric heart failure: 50 years lost to improve pharmacotherapy of a deadly disease.
Buchhorn R
Ann Pediatr Cardiol; 2021; 14(3):341-342. PubMed ID: 34667405
[No Abstract] [Full Text] [Related]
9. Treatment and outcomes in patients with myocardial infarction treated with acute β-blocker therapy: results from the American College of Cardiology's NCDR(®).
Kontos MC; Diercks DB; Ho PM; Wang TY; Chen AY; Roe MT
Am Heart J; 2011 May; 161(5):864-70. PubMed ID: 21570515
[TBL] [Abstract][Full Text] [Related]
10. Early intravenous beta-blockers in patients with acute coronary syndrome--a meta-analysis of randomized trials.
Chatterjee S; Chaudhuri D; Vedanthan R; Fuster V; Ibanez B; Bangalore S; Mukherjee D
Int J Cardiol; 2013 Sep; 168(2):915-21. PubMed ID: 23168009
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of carvedilol versus beta 1 selective beta-blockers (atenolol, bisoprolol, metoprolol, and nebivolol).
DiNicolantonio JJ; Lavie CJ; Fares H; Menezes AR; O'Keefe JH
Am J Cardiol; 2013 Mar; 111(5):765-9. PubMed ID: 23290925
[TBL] [Abstract][Full Text] [Related]
12. Does the early administration of beta-blockers improve the in-hospital mortality rate of patients admitted with acute coronary syndrome?
Brandler E; Paladino L; Sinert R
Acad Emerg Med; 2010 Jan; 17(1):1-10. PubMed ID: 20078433
[TBL] [Abstract][Full Text] [Related]
13. Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction.
Yusuf S; Wittes J; Friedman L
JAMA; 1988 Oct; 260(14):2088-93. PubMed ID: 2901501
[No Abstract] [Full Text] [Related]
14. Effect of Beta-Blocker Dose on Survival After Acute Myocardial Infarction.
Goldberger JJ; Bonow RO; Cuffe M; Liu L; Rosenberg Y; Shah PK; Smith SC; Subačius H;
J Am Coll Cardiol; 2015 Sep; 66(13):1431-41. PubMed ID: 26403339
[TBL] [Abstract][Full Text] [Related]
15. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group.
Lancet; 1986 Jul; 2(8498):57-66. PubMed ID: 2873379
[TBL] [Abstract][Full Text] [Related]
16. Effect of oral β-blocker treatment on mortality in contemporary post-myocardial infarction patients: a systematic review and meta-analysis.
Dahl Aarvik M; Sandven I; Dondo TB; Gale CP; Ruddox V; Munkhaugen J; Atar D; Otterstad JE
Eur Heart J Cardiovasc Pharmacother; 2019 Jan; 5(1):12-20. PubMed ID: 30192930
[TBL] [Abstract][Full Text] [Related]
17. Importance of reassessment to identify trajectories of chronic transition of clinical indicators in post-myocardial infarction management.
Yoshioka G; Tanaka A; Sonoda S; Kaneko T; Hongo H; Yokoi K; Natsuaki M; Node K
Cardiovasc Interv Ther; 2024 Jul; 39(3):234-240. PubMed ID: 38615302
[TBL] [Abstract][Full Text] [Related]
18. Beta-Blockers in the Prevention and Treatment of Ischemic Heart Disease: Evidence and Clinical Practice.
Khan O; Patel M; Tomdio AN; Beall J; Jovin IS
Heart Views; 2023; 24(1):41-49. PubMed ID: 37124437
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of diabetic patients with non-ST-segment elevation myocardial infarction.
Li Z; Huang S; Yang R; Li J; Chen G
Am J Transl Res; 2021; 13(12):13870-13877. PubMed ID: 35035727
[TBL] [Abstract][Full Text] [Related]
20. Relationship Between β-Blocker Therapy at Discharge and Clinical Outcomes in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
Li C; Sun Y; Shen X; Yu T; Li Q; Ruan G; Zhang L; Huang Q; Zhuang H; Huang J; Ni L; Wang L; Jiang J; Wang Y; Wang DW
J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27852588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
